Cargando…

Elevated expression of podoplanin and its clinicopathological, prognostic, and therapeutic values in squamous non-small cell lung cancer

BACKGROUND: Squamous non-small cell lung cancer (SqNSCLC), as a leading cause of cancer-related deaths worldwide, has limited treatment options and poor prognosis. Thus, novel targeted therapies are desperately needed. MATERIALS AND METHODS: SqNSCLC cases from derivation and validation cohorts were...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Liyi, Lin, Chen, Zhang, Qingfu, Piao, Hailan, Bigner, Darell D, Zhang, Zhen, Bao, Xuhui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973461/ https://www.ncbi.nlm.nih.gov/pubmed/29872344 http://dx.doi.org/10.2147/CMAR.S163510

Ejemplares similares

Prognostic Value of Podoplanin in Various Tumors
por: Wang, Xiaohang, et al.
Publicado: (2021)

EGFR/EGFRvIII-targeted immunotoxin therapy for the treatment of glioblastomas via convection-enhanced delivery
por: Bao, Xuhui, et al.
Publicado: (2016)

Elevated Soluble Podoplanin Associates with Hypercoagulability in Patients with Nephrotic Syndrome
por: Ji, Ying, et al.
Publicado: (2022)

The Role of Podoplanin in the Lymphangiogenesis of Oral Squamous Carcinomas
por: CIUREA, R.N., et al.
Publicado: (2015)

The prognostic values of the expression of Vimentin, TP53, and Podoplanin in patients with cervical cancer
por: Lin, Jiaying, et al.
Publicado: (2017)

Immunotoxin Therapy for Lung Cancer
por: Xie, Li-Yi, et al.
Publicado: (2017)

Podoplanin: A potential therapeutic target for thrombotic diseases
por: Huang, Yaqian, et al.
Publicado: (2023)

Prognostic value of podoplanin expression in intratumoral stroma and neoplastic cells of uterine cervical carcinomas
por: Carvalho, Filomena M, et al.
Publicado: (2010)

Podoplanin: An emerging cancer biomarker and therapeutic target
por: Krishnan, Harini, et al.
Publicado: (2018)

Podoplanin expression in the development and progression of laryngeal squamous cell carcinomas
por: Rodrigo, Juan P, et al.
Publicado: (2010)

Expression of Podoplanin in Different Grades of Oral Squamous Cell Carcinoma
por: Prasad, B, et al.
Publicado: (2015)

Evaluation of Podoplanin in Oral Leukoplakia and Oral Squamous Cell Carcinoma
por: Patil, Ashok, et al.
Publicado: (2015)

Study of Podoplanin Expression in Head and Neck Squamous Cell Carcinoma
por: Mary Jibi, Anjali, et al.
Publicado: (2022)

Podoplanin is an important stromal prognostic marker in perihilar cholangiocarcinoma
por: Obulkasim, Halmurat, et al.
Publicado: (2018)

Podoplanin, a Potential Therapeutic Target for Nasopharyngeal Carcinoma
por: Hsu, Yen-Bin, et al.
Publicado: (2019)

Prognostic Potential of the Expression of Podoplanin (D2-40) Within Cells of Squamous Cell Carcinoma of the Larynx and Hypopharynx
por: Voelker, Hans-Ullrich, et al.
Publicado: (2020)

Expression of podoplanin and vimentin is correlated with prognosis in esophageal squamous cell carcinoma
por: TANAKA, MAKIKO, et al.
Publicado: (2015)

Immunohistochemical Expression of VEGF and Podoplanin in Uterine Cervical Squamous Intraepithelial Lesions
por: Belfort-Mattos, Patrícia Napoli, et al.
Publicado: (2016)

Prognostic and clinicopathological value of ZIC1 in patients with cervical squamous cell carcinoma
por: Gu, Xing, et al.
Publicado: (2019)

A novel recombinant immunotoxin-based therapy targeting wild-type and mutant EGFR improves survival in murine models of glioblastoma
por: Chandramohan, Vidyalakshmi, et al.
Publicado: (2013)

Podoplanin in Inflammation and Cancer
por: Quintanilla, Miguel, et al.
Publicado: (2019)

Podoplanin expression in oral potentially malignant disorders and oral squamous cell carcinoma
por: A G, Deepa, et al.
Publicado: (2017)

The Role of Podoplanin in the Immune System and Inflammation
por: Zhang, Zhiyuan, et al.
Publicado: (2022)

Podoplanin is a useful prognostic marker and indicates better differentiation in lung squamous cell cancer patients? A systematic review and meta-analysis
por: Hu, Liya, et al.
Publicado: (2020)

The prognostic value of B7-H6 in esophageal squamous cell carcinoma
por: Zhou, Huan, et al.
Publicado: (2019)

Clinicopathological Correlations of Podoplanin (gp38) Expression in Rheumatoid Synovium and Its Potential Contribution to Fibroblast Platelet Crosstalk
por: Del Rey, Manuel J., et al.
Publicado: (2014)

The Role of Podoplanin in Skin Diseases
por: Asai, Jun
Publicado: (2022)

Targeting Podoplanin for the Treatment of Osteosarcoma
por: Takemoto, Ai, et al.
Publicado: (2022)

Podoplanin mediates ECM degradation by squamous carcinoma cells through control of invadopodia stability
por: Martín-Villar, E, et al.
Publicado: (2015)

Interplay between Podoplanin, CD44s and CD44v in Squamous Carcinoma Cells
por: Montero-Montero, Lucía, et al.
Publicado: (2020)

Prognostic value of clinicopathological parameters in head and neck squamous cell carcinoma: a prospective analysis.
por: Janot, F., et al.
Publicado: (1996)

Antitumor efficacy of D2C7-(scdsFv)-PE38KDEL, a novel immunotoxin targeting EGFRwt and EGFRvIII, by convection-enhanced delivery in orthotopic brain tumor mouse models
por: Bao, Xuhui, et al.
Publicado: (2013)

The expression of podoplanin protein is a diagnostic marker to distinguish the early infiltration of esophageal squamous cell carcinoma
por: Chen, Guangyong, et al.
Publicado: (2017)

Direct Contact with Platelets Induces Podoplanin Expression and Invasion in Human Oral Squamous Cell Carcinoma Cells
por: Park, Se-Young, et al.
Publicado: (2022)

A Comparison of Podoplanin Expression in Oral Leukoplakia and Oral Squamous Cell Carcinoma: An Immunohistochemical Study
por: Srinivasan, Vaishnavi, et al.
Publicado: (2023)

Podoplanin promotes cell proliferation, survival, and migration of canine non-tonsillar squamous cell carcinoma
por: SHINADA, Masahiro, et al.
Publicado: (2023)

The potential role of podoplanin in tumour invasion
por: Wicki, A, et al.
Publicado: (2007)

Roles of Podoplanin in Malignant Progression of Tumor
por: Suzuki, Hiroyuki, et al.
Publicado: (2022)

Prognostic Value Analysis of Mutational and Clinicopathological Factors in Non-Small Cell Lung Cancer
por: Li, Chenguang, et al.
Publicado: (2014)

BIOL-10. DISTRIBUTION AND VULNERABILITY OF TRANSCRIPTIONAL OUTPUTS ACROSS THE GENOME IN MYC-AMPLIFIED MEDULLOBLASTOMA CELLS
por: Yang, Rui, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jm2rq082bgk17lh3c7d44vpelj